Molecular and clinical correlates of DSCR1 expression in pancreatic cancer (PDAC). First in class TLR7/8 agonist BDB001 combined with atezolizumab and stereotactic body radiation therapy in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback